{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:56:06Z","timestamp":1782957366972,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ygyno.2007.07.078","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T16:27:33Z","timestamp":1196094453000},"page":"S27-S30","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S","title":["Long-term efficacy of human papillomavirus vaccination"],"prefix":"10.1016","volume":"107","author":[{"given":"Kevin A.","family":"Ault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.07.078_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0264-410X(00)00224-3","article-title":"Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory","volume":"19","author":"Banatvala","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2007.07.078_bib2","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/eji.1830250919","article-title":"Stimulation of a memory B cell response does not require primed helper T cells","volume":"25","author":"Leclerc","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ygyno.2007.07.078_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.14.1.333","article-title":"On immunological memory","volume":"14","author":"Zinkernagel","year":"1996","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.ygyno.2007.07.078_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.immunol.23.021704.115732","article-title":"Antigen-specific memory B cell development","volume":"23","author":"McHeyzer-Williams","year":"2005","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.ygyno.2007.07.078_bib5","first-page":"561","article-title":"Are booster immunizations needed for lifelong hepatitis B immunity","volume":"355","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2007.07.078_bib6","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/S0264-410X(02)00405-X","article-title":"Immunogenicity of hepatitis B vaccines: implications of immune memory","volume":"20","author":"Koff","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2007.07.078_bib7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ygyno.2007.07.078_bib8","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ygyno.2007.07.078_bib9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5\u00a0years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2007.07.078_bib10","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","article-title":"Enhanced humoral and memory B cellular immunity using HPV 16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only","volume":"24","author":"Giannini","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2007.07.078_bib11","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ygyno.2007.07.078_bib12","doi-asserted-by":"crossref","DOI":"10.4161\/hv.3.4.4309","article-title":"Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice","volume":"3","author":"Caulfield","year":"2007","journal-title":"Hum Vaccin"},{"issue":"25","key":"10.1016\/j.ygyno.2007.07.078_bib13","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.vaccine.2007.02.069","article-title":"Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.ygyno.2007.07.078_bib14","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1128\/JVI.76.15.7832-7842.2002","article-title":"Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine","volume":"76","author":"Emeny","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.07.078_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.virol.2006.06.021","article-title":"Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles","volume":"353","author":"Pinto","year":"2006","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.ygyno.2007.07.078_bib16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ygyno.2007.07.078_bib17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2007.07.078_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1386-6532(00)00141-4","article-title":"Prospects for phase III\u2013IV HPV vaccination trials in the Nordic countries and in Estonia","volume":"19","author":"Lehtinen","year":"2000","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2007.07.078_bib19","first-page":"S3233","article-title":"Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries","volume":"24S3","author":"Lehtinen","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ygyno.2007.07.078_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1258\/095646206776253453","article-title":"Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy","volume":"17","author":"Lehtinen","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ygyno.2007.07.078_bib21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Pavonen","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ygyno.2007.07.078_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1258\/095646206778145550","article-title":"Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing","volume":"17","author":"Lehtinen","year":"2006","journal-title":"Int J STD AIDS"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807005720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807005720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T15:25:54Z","timestamp":1546442754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807005720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0090825807005720"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.07.078","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}